Wholesale acquisition cost of agents recommended for prevention of opportunistic infections in patients who have HIV infection
Opportunistic Pathogen | Drug | Dose | Annual Cost |
Pneumocystis carinii |
-Trimethoprim-sulfamethoxazole -Dapsone -Aerosolized pentamidine |
160/800 mg q.d. 100 mg q.d. 300 mg q.m. |
$60 $72 $1,185 |
Mycobacterium avium complex |
-Rifabutin -Clarithromycin -Azithromycin |
300 mg q.d. 500 mg b.i.d. 1,200 mg q.w. |
$ 2,916 $ 2,347 $1,490 |
Cytomegalovirus |
-Ganciclovir (iv) -Foscarnet (iv) -Ganciclovir (po) -Cidofovir (iv) -Ganciclovir implant |
5 mg/kg q.d. 90120 mg/kg q.d. 1,000 mg t.i.d. 375 mg q.o.w. -- |
$8,891 $27,80037,200 $17,082 $17,670 $5,000 |
Mycobacterium tuberculosis |
-Isoniazid -Rifampin -Pyrazinamide -Ethambutol |
300 mg q.d. 600 mg q.d. 1500 mg q.d. 900 mg q.d. |
$31 $1,542 $1,187 $1,370 |
Fungi |
-Fluconazole -Itraconazole -Ketoconazole |
200 mg q.d. 200 mg q.d. 200 mg q.d. |
$5,018 $4,239 $1,069 |
Herpes simplex virus | -Acyclovir | 400 mg t.i.d. | $2,377 |
Toxoplasma gondii |
-Pyrimethamine -Leucovorin |
500 mg q.w. 25 mg q.w. |
$43 $727 |
Pathogen | Vaccine | Dose | Cost per dose listed |
Streptococcus pneumoniae | 23-valent pneumococcal | 0.5 mL im | $15 |
Influenza virus | Influenza vaccine | 0.5 mL im | $5 |
Hepatitis B virus | Recombinant hepatitis B | 1020 µg im x 3 | $173 |
Source: Drug Topics Red Book, Medical Economics Inc., Montvale, NJ, 1997.
Go to the USPHS/IDSA Guidelines Menu
Go to the Opportunistic Infections Menu
Go to the HIVpositive.us Main Menu